Nuvation Bio Inc. is trading 5.9% up today at $5.04, rebounding after a brief pullback and consolidation phase earlier this week.
- The stock is regaining momentum following a sell-off on June 11, 2026, which was driven by profit-taking after a sharp analyst-driven rally.
- The initial surge was sparked on June 9, 2026, when RBC Capital issued an Outperform rating and a significant price target boost.
- Today’s price action suggests a continuation of the positive sentiment established by the recent upgrade as buyers step back into the market.